CD73 promotes tumor metastasis by modulating RICS/RhoA signaling and EMT in gastric cancer
Open Access
- 23 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Disease
- Vol. 11 (3), 1-15
- https://doi.org/10.1038/s41419-020-2403-6
Abstract
Tumor microenvironment plays vital roles in shaping cancer diversity, and CD73 (ecto-5′-nucleotidase; NT5E) is an emerging immune checkpoint in modulating cancer progression via conversion of immunostimulatory ATP into immunosuppressive adenosine. However, how the CD73 is regulated and how it functions in the progression of cancer are largely unknown. Here, we showed that CD73 was overexpressed and correlated with poor prognosis of gastric cancer. CD73 links adenosinergic signaling in microenvironment switching to induction of epithelial-to-mesenchymal transition phenotype in gastric cancer during metastasis. Further pathway and gene set enrichment analysis of transcriptome data revealed the modulation role of CD73 in RICS/RhoA signaling by its extracellular function in adenosinergic pathway, which subsequently inhibited phosphorylation of LIMK/cofilin and promoted β-catenin activation. Pharmacological inhibition of CD73 adenosinergic signaling was found to induce RICS dysfunction. Dissemination and hematogenous metastasis model showed that targeting CD73 in gastric cancer could suppress experimental metastasis. To conclude, it substantiates CD73 as a target for treatment of gastric cancer metastasis and verifies RICS as an intracellular functional molecule linking CD73/adenosinergic signaling switching to RhoA/LIMK/cofilin pathway.Keywords
This publication has 56 references indexed in Scilit:
- Identification of Molecular Subtypes of Gastric Cancer With Different Responses to PI3-Kinase Inhibitors and 5-FluorouracilGastroenterology, 2013
- CD73: a potent suppressor of antitumor immune responsesTrends in Immunology, 2012
- CD73-Deficient Mice Are Resistant to CarcinogenesisCancer Research, 2012
- CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in miceJCI Insight, 2011
- Immune cell regulation by autocrine purinergic signallingNature Reviews Immunology, 2011
- Extracellular adenosine triphosphate and adenosine in cancerOncogene, 2010
- Anti-CD73 antibody therapy inhibits breast tumor growth and metastasisProceedings of the National Academy of Sciences of the United States of America, 2010
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- p250GAP, a Novel Brain-enriched GTPase-activating Protein for Rho Family GTPases, Is Involved in theN-Methyl-d-aspartate Receptor SignalingMolecular Biology of the Cell, 2003
- RICS, a Novel GTPase-activating Protein for Cdc42 and Rac1, Is Involved in the β-Catenin-N-cadherin andN-Methyl-d-aspartate Receptor SignalingOnline Journal of Public Health Informatics, 2003